{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:54:52Z","timestamp":1790142892584,"version":"4.0.1"},"reference-count":62,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1210\/jc.2012-3566","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T02:41:38Z","timestamp":1368240098000},"page":"2811-2821","source":"Crossref","is-referenced-by-count":106,"title":["DNA Methylation Signatures Identify Biologically Distinct Thyroid Cancer Subtypes"],"prefix":"10.1210","volume":"98","author":[{"given":"Sandra","family":"Rodr\u00edguez-Rodero","sequence":"first","affiliation":[{"name":"Departments of Endocrinology and Nutrition (S.R.-R., J.L.F.-M., E.D.-A., E.M.-T.), 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn F.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Pathology (I.F.-V., M.F.F.F.), 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Lu\u00eds","family":"Fern\u00e1ndez-Morera","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology and Nutrition (S.R.-R., J.L.F.-M., E.D.-A., E.M.-T.), 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Castro-Santos","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics Laboratory (A.F.F., P.C.-S., G.F.B., C.F., R.G.U., M.F.F.), 33006 Oviedo, Spain;"},{"name":"Facultad de Ciencias de la Salud (P.C.-S.), Universidad Aut\u00f3noma de Chile, Alemania 1090, Chile;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo F.","family":"Bayon","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics Laboratory (A.F.F., P.C.-S., G.F.B., C.F., R.G.U., M.F.F.), 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Ferrero","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics Laboratory (A.F.F., P.C.-S., G.F.B., C.F., R.G.U., M.F.F.), 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio G.","family":"Urdinguio","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics Laboratory (A.F.F., P.C.-S., G.F.B., C.F., R.G.U., M.F.F.), 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Gonzalez-Marquez","sequence":"additional","affiliation":[{"name":"Servicio de Otorrinolaringolog\u00eda (R.G.-M., C.S.), Instituto Universitario de Oncolog\u00eda del Principado de Asturias, Hospital Universitario Central de Asturias; 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Suarez","sequence":"additional","affiliation":[{"name":"Servicio de Otorrinolaringolog\u00eda (R.G.-M., C.S.), Instituto Universitario de Oncolog\u00eda del Principado de Asturias, Hospital Universitario Central de Asturias; 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Fern\u00e1ndez-Vega","sequence":"additional","affiliation":[{"name":"Pathology (I.F.-V., M.F.F.F.), 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Florentino","family":"Fresno Forcelledo","sequence":"additional","affiliation":[{"name":"Pathology (I.F.-V., M.F.F.F.), 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mart\u00ednez-Camblor","sequence":"additional","affiliation":[{"name":"Oficina de Investigaci\u00f3n Biosanitaria de Asturias (P.M.-C.) 33005 Oviedo, Spain,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Mancikova","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (V.M., M.R.), Spanish National Cancer Research Center, Madrid, Spain, and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades 28029 Raras, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Castelblanco","sequence":"additional","affiliation":[{"name":"Departamento de Patologia y Genetica Molecular (E.C., X.M.-G.), Hospital Universitario Arnau de Vilanova, Universidad de Lerida, 25198 Lerida, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Perez","sequence":"additional","affiliation":[{"name":"Instituto de Biomedicina de Sevilla (M.P., A.C.), Hospital Universitario Virgen del Roc\u00edo\/Consejo Superior de Investigaciones Cient\u00edficas (CSIC)\/Universidad de Sevilla, Departamento de Oncohematologia y Genetica, 41013 Sevilla, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Isidro","family":"Marr\u00f3n","sequence":"additional","affiliation":[{"name":"Biobanco Hospital Universitario Central de Asturias (P.M.) 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mendiola","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology and Oncology (M.M.), Research Unit, Madrid 28049, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hardisson","sequence":"additional","affiliation":[{"name":"Departments of Pathology (D.H.), Madrid 28049, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Santisteban","sequence":"additional","affiliation":[{"name":"Instituto de Investigaciones Biom\u00e9dicas \u201cAlberto Sols\u201d (P.S.) 28029 Madrid, Spain, CSIC-Universidad Aut\u00f3noma de Madrid; Madrid 28049, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garcilaso","family":"Riesco-Eizaguirre","sequence":"additional","affiliation":[{"name":"Endocrinology (G.R.-E.), Hospital Universitario La Paz, Instituto de Investigaci\u00f3n Hospital Universitario La Paz 28046; Madrid 28049, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mat\u00edas-Guiu","sequence":"additional","affiliation":[{"name":"Departamento de Patologia y Genetica Molecular (E.C., X.M.-G.), Hospital Universitario Arnau de Vilanova, Universidad de Lerida, 25198 Lerida, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amancio","family":"Carnero","sequence":"additional","affiliation":[{"name":"Instituto de Biomedicina de Sevilla (M.P., A.C.), Hospital Universitario Virgen del Roc\u00edo\/Consejo Superior de Investigaciones Cient\u00edficas (CSIC)\/Universidad de Sevilla, Departamento de Oncohematologia y Genetica, 41013 Sevilla, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group (V.M., M.R.), Spanish National Cancer Research Center, Madrid, Spain, and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades 28029 Raras, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00edas","family":"Delgado-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology and Nutrition (S.R.-R., J.L.F.-M., E.D.-A., E.M.-T.), 33006 Oviedo, Spain;"},{"name":"Department of Medicine (E.D.-A.), Universidad de Oviedo, 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edelmiro","family":"Men\u00e9ndez-Torre","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology and Nutrition (S.R.-R., J.L.F.-M., E.D.-A., E.M.-T.), 33006 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario F.","family":"Fraga","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics Laboratory (A.F.F., P.C.-S., G.F.B., C.F., R.G.U., M.F.F.), 33006 Oviedo, Spain;"},{"name":"Department of Immunology and Oncology (M.F.F.), Centro Nacional de Biotecnolog\u00eda\/CSIC, Cantoblanco, Madrid 28049, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113221489400_B1","first-page":"255","article-title":"New approaches to thyroid cancer","volume":"10","author":"Cohen","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"key\n\t\t\t\t2019041113221489400_B2","article-title":"Cancer of the endocrine system","volume-title":"Principles and Practice of Oncology","author":"DeVita","year":"2008","edition":"8th ed"},{"key":"key\n\t\t\t\t2019041113221489400_B3","doi-asserted-by":"crossref","first-page":"E2031","DOI":"10.1210\/jc.2012-2092","article-title":"Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon","volume":"97","author":"Boichard","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113221489400_B4","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/jc.2012-2104","article-title":"BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis","volume":"97","author":"Li","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113221489400_B5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/dc.21725","article-title":"Examination of CD26\/DPPIV, p53, and PTEN expression in thyroid follicular adenoma","volume":"40","author":"Miyake","year":"2012","journal-title":"Diagn Cytopathol"},{"key":"key\n\t\t\t\t2019041113221489400_B6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fendo.2012.00054","article-title":"RET\/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma","volume":"3","author":"Romei","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key\n\t\t\t\t2019041113221489400_B7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2174\/138920211798120835","article-title":"Genetic Alterations in Medullary Thyroid Cancer: Diagnostic and Prognostic Markers","volume":"12","author":"A","year":"2011","journal-title":"Curr Genom"},{"key":"key\n\t\t\t\t2019041113221489400_B8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archotol.133.10.1006","article-title":"Methylation status of genes in papillary thyroid carcinoma","volume":"133","author":"Smith","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key\n\t\t\t\t2019041113221489400_B9","first-page":"2449","article-title":"Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+\/I\u2212 symporter gene methylation status","volume":"84","author":"Venkataraman","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113221489400_B10","first-page":"2316","article-title":"Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing","volume":"63","author":"Xing","year":"2003","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041113221489400_B11","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3390\/cancers3021732","article-title":"DNA methylation in thyroid tumorigenesis","volume":"3","author":"Stephen","year":"2011","journal-title":"Cancers (Basel)"},{"key":"key\n\t\t\t\t2019041113221489400_B12","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1038\/onc.2011.18","article-title":"TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells","volume":"30","author":"Anania","year":"2011","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019041113221489400_B13","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/ijc.22110","article-title":"Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer","volume":"119","author":"Hu","year":"2006","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t2019041113221489400_B14","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1158\/0008-5472.CAN-03-3242","article-title":"Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis","volume":"64","author":"Xing","year":"2004","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041113221489400_B15","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol"},{"key":"key\n\t\t\t\t2019041113221489400_B16","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1038\/sj.onc.1208822","article-title":"Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET\/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis","volume":"24","author":"Giordano","year":"2005","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019041113221489400_B17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cell.2006.02.043","article-title":"Control of developmental regulators by polycomb in human embryonic stem cells","volume":"125","author":"Lee","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019041113221489400_B18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.stem.2007.08.003","article-title":"Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells","volume":"1","author":"Pan","year":"2007","journal-title":"Cell Stem Cell"},{"key":"key\n\t\t\t\t2019041113221489400_B19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.bjc.6603006","article-title":"Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours","volume":"94","author":"Dunn","year":"2006","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2019041113221489400_B20","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1158\/0008-5472.CAN-11-1630","article-title":"Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence","volume":"71","author":"Fackler","year":"2011","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041113221489400_B21","doi-asserted-by":"crossref","first-page":"e16916","DOI":"10.1371\/journal.pone.0016916","article-title":"ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer","volume":"6","author":"Gan","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041113221489400_B22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/35079135","article-title":"Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor","volume":"411","author":"Ohtaki","year":"2001","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041113221489400_B23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1677\/erc.1.00975","article-title":"Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility","volume":"12","author":"Brandt","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t2019041113221489400_B24","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-07-1322","article-title":"ECSA\/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer","volume":"14","author":"John","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2019041113221489400_B25","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1074\/jbc.M107069200","article-title":"Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family","volume":"277","author":"Laine","year":"2002","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113221489400_B26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4614-0899-4_7","article-title":"Notch signaling in lung development and disease","volume":"727","author":"Xu","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"key\n\t\t\t\t2019041113221489400_B27","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1093\/carcin\/bgm124","article-title":"MAP17 enhances the malignant behavior of tumor cells through ROS increase","volume":"28","author":"Guijarro","year":"2007","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t2019041113221489400_B28","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/carcin\/bgm083","article-title":"MAP17 overexpression is a common characteristic of carcinomas","volume":"28","author":"Guijarro","year":"2007","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t2019041113221489400_B29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat Rev Genet"},{"key":"key\n\t\t\t\t2019041113221489400_B30","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI31457","article-title":"Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma","volume":"117","author":"Calvisi","year":"2007","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113221489400_B31","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1093\/hmg\/ddp354","article-title":"The DNA methylome of pediatric acute lymphoblastic leukemia","volume":"18","author":"Davidsson","year":"2009","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t2019041113221489400_B32","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4161\/cbt.7.7.6208","article-title":"Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma","volume":"7","author":"Omura","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"key\n\t\t\t\t2019041113221489400_B33","doi-asserted-by":"crossref","first-page":"895470","DOI":"10.4061\/2011\/895470","article-title":"The role of epigenetic alterations in papillary thyroid carcinogenesis","volume":"2011","author":"Eze","year":"2011","journal-title":"J Thyroid Res"},{"key":"key\n\t\t\t\t2019041113221489400_B34","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/cncr.23869","article-title":"Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase\/AKT signaling pathway in thyroid tumors","volume":"113","author":"Hou","year":"2008","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041113221489400_B35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000110028","article-title":"DNA hypermethylation status of multiple genes in papillary thyroid carcinomas","volume":"74","author":"Ishida","year":"2007","journal-title":"Pathobiology"},{"key":"key\n\t\t\t\t2019041113221489400_B36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1101\/gr.119867.110","article-title":"A DNA methylation fingerprint of 1628 human samples","volume":"22","author":"Fernandez","year":"2012","journal-title":"Genome Res"},{"key":"key\n\t\t\t\t2019041113221489400_B37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1634\/stemcells.2006-0269","article-title":"Dppa2 and Dppa4 are closely linked SAP motif genes restricted to pluripotent cells and the germ line","volume":"25","author":"Maldonado-Saldivia","year":"2007","journal-title":"Stem Cells"},{"key":"key\n\t\t\t\t2019041113221489400_B38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4419-9967-2_7","article-title":"DNA hypomethylation and activation of germline-specific genes in cancer","volume":"754","author":"De Smet","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"key\n\t\t\t\t2019041113221489400_B39","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.25870","article-title":"Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors","volume":"56","author":"Neumann","year":"2012","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019041113221489400_B40","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/hep.25569","article-title":"Genome-wide DNA methylation profiles in hepatocellular carcinoma","volume":"55","author":"Shen","year":"2012","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019041113221489400_B41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/nar\/gkr685","article-title":"A promoter DNA demethylation landscape of human hematopoietic differentiation","volume":"40","author":"Calvanese","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019041113221489400_B42","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood-2006-05-024661","article-title":"Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications","volume":"109","author":"Gonzalez-Paz","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041113221489400_B43","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/gb-2010-11-6-r63","article-title":"Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels","volume":"11","author":"Klug","year":"2010","journal-title":"Genome Biol"},{"key":"key\n\t\t\t\t2019041113221489400_B44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrg3270","article-title":"DNA methylation profiling in the clinic: applications and challenges","volume":"13","author":"Heyn","year":"2012","journal-title":"Nat Rev Genet"},{"key":"key\n\t\t\t\t2019041113221489400_B45","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/onc.2011.307","article-title":"DNA hypermethylation in lung cancer is targeted at differentiation-associated genes","volume":"31","author":"Helman","year":"2012","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019041113221489400_B46","doi-asserted-by":"crossref","first-page":"e44822","DOI":"10.1371\/journal.pone.0044822","article-title":"Distinct functional patterns of gene promoter hypomethylation and hypermethylation in cancer genomes","volume":"7","author":"Shen","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041113221489400_B47","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.4161\/cc.6.9.4210","article-title":"Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation?","volume":"6","author":"Ohm","year":"2007","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t2019041113221489400_B48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ng1950","article-title":"Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer","volume":"39","author":"Schlesinger","year":"2007","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041113221489400_B49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ng1941","article-title":"Epigenetic stem cell signature in cancer","volume":"39","author":"Widschwendter","year":"2007","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041113221489400_B50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1078\/0344-0338-00436","article-title":"Hypermethylation of the CDKN2\/p16INK4A promotor in thyroid carcinogenesis","volume":"199","author":"Boltze","year":"2003","journal-title":"Pathol Res Pract"},{"key":"key\n\t\t\t\t2019041113221489400_B51","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1245\/s10434-006-9280-9","article-title":"Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma","volume":"14","author":"Lam","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"key\n\t\t\t\t2019041113221489400_B52","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/labinvest.3700306","article-title":"RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors","volume":"85","author":"Nakamura","year":"2005","journal-title":"Lab Invest"},{"key":"key\n\t\t\t\t2019041113221489400_B53","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/0008-5472.CAN-09-2812","article-title":"Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumors","volume":"70","author":"Zuo","year":"2010","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041113221489400_B54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/thy.2006.16.17","article-title":"PTEN promoter methylation in sporadic thyroid carcinomas","volume":"16","author":"Alvarez-Nu\u00f1ez","year":"2006","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113221489400_B55","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1210\/jcem.87.5.8626","article-title":"Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells","volume":"87","author":"Ringel","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113221489400_B56","first-page":"216","article-title":"HOX genes in pancreatic development and cancer","volume":"12","author":"Gray","year":"2011","journal-title":"JOP"},{"key":"key\n\t\t\t\t2019041113221489400_B57","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/sj.bjc.6602107","article-title":"METH-2 silencing and promoter hypermethylation in NSCLC","volume":"91","author":"Dunn","year":"2004","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2019041113221489400_B58","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1158\/1078-0432.CCR-07-0919","article-title":"Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis","volume":"13","author":"Strathdee","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2019041113221489400_B59","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/thy.2010.0444","article-title":"Delta-like 4\/Notch pathway is differentially regulated in benign and malignant thyroid tissues","volume":"21","author":"Geers","year":"2011","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113221489400_B60","first-page":"363","article-title":"Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma","volume":"24","author":"Ding","year":"2010","journal-title":"Oncol Rep"},{"key":"key\n\t\t\t\t2019041113221489400_B61","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/gcc.1099","article-title":"TCL1 is activated by chromosomal rearrangement or by hypomethylation","volume":"30","author":"Yuille","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t2019041113221489400_B62","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1210\/jcem.82.9.4359","article-title":"Identification of pro-EPIL and EPIL peptides translated from insulin-like 4 (INSL4) mRNA in human placenta","volume":"82","author":"Bellet","year":"1997","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/7\/2811\/9047445\/jcem2811.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T17:37:17Z","timestamp":1563039437000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/7\/2811\/2537028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-3566","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,1]]}}}